Skip to main content

Table 4 Survival by change in PG-SGA from T0 to T2

From: Bioelectrical impedance analysis for monitoring cancer patients receiving chemotherapy and home parenteral nutrition

 

N (%)

Survival

Median (range)

Improved

 B to A

5 (7.7%)

652 (398–693)

 C to B

15 (23.1%)

311 (108–772)

Stayed the Same

 B to B

16 (24.6%)

452 (230–790)

 C to C

19 (29.2%)

162 (92–765)

 Declined

 B to C

10 (15.4%)

156 (92–376)

  1. PG-SGA Patient-generated subjective global assessment, Category A = well-nourished; Category B = suspected malnutrition or moderate malnutrition; Category C = severely malnourished; T0 = baseline, T2 = 90 days after the start of home parenteral nutrition